▶ 調査レポート

世界のボツリヌス中毒症薬市場予測(~2024年)

• 英文タイトル:Global Botulism Illness Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のボツリヌス中毒症薬市場予測(~2024年) / Global Botulism Illness Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / B-GIR09D3820資料のイメージです。• レポートコード:B-GIR09D3820
• 出版社/出版日:GlobalInfoResearch / 2019年9月18日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、ボツリヌス中毒症薬の世界市場について調べ、まとめました。種類別セグメントは、抗生物質、抗毒素、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。ボツリヌス中毒症薬の世界市場概観、企業動向、企業別ボツリヌス中毒症薬シェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・ボツリヌス中毒症薬の市場概観
・ボツリヌス中毒症薬の企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・ボツリヌス中毒症薬の企業別販売動向、市場シェア、市場集中度、競争動向
・ボツリヌス中毒症薬の世界市場規模
・ボツリヌス中毒症薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・ボツリヌス中毒症薬のアメリカ市場規模推移
・ボツリヌス中毒症薬のカナダ市場規模推移
・ボツリヌス中毒症薬のメキシコ市場規模推移
・ボツリヌス中毒症薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・ボツリヌス中毒症薬のドイツ市場規模推移
・ボツリヌス中毒症薬のイギリス市場規模推移
・ボツリヌス中毒症薬のロシア市場規模推移
・ボツリヌス中毒症薬のアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・ボツリヌス中毒症薬の日本市場規模推移
・ボツリヌス中毒症薬の中国市場規模推移
・ボツリヌス中毒症薬の韓国市場規模推移
・ボツリヌス中毒症薬のインド市場規模推移
・ボツリヌス中毒症薬の東南アジア市場規模推移
・ボツリヌス中毒症薬の南米市場分析(ブラジル、アルゼンチン等)
・ボツリヌス中毒症薬の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・ボツリヌス中毒症薬の種類別分析/販売量、売上、市場シェア(抗生物質、抗毒素、その他)
・ボツリヌス中毒症薬の用途別分析/市場規模(病院、診療所、その他)
・ボツリヌス中毒症薬の市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・ボツリヌス中毒症薬の販売チャネル・代理店・貿易業者・ディーラー分析

Botulism is a rare and potentially fatal illness caused by a toxin produced by the bacterium Clostridium botulinum. The disease begins with weakness, blurred vision, feeling tired, and trouble speaking. This may then be followed by weakness of the arms, chest muscles, and legs. Vomiting, swelling of the abdomen, and diarrhea may also occur. The disease does not usually affect consciousness or cause a fever.

Scope of the Report:
The global Botulism Illness Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Botulism Illness Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Botulism Illness Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Botulism Illness Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers
Eisai
Microbiotix

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Antibiotics
Antitoxins
Other

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

レポート目次

Table of Contents

1 Botulism Illness Drugs Market Overview
1.1 Product Overview and Scope of Botulism Illness Drugs
1.2 Classification of Botulism Illness Drugs by Types
1.2.1 Global Botulism Illness Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Botulism Illness Drugs Revenue Market Share by Types in 2018
1.2.3 Antibiotics
1.2.4 Antitoxins
1.2.5 Other
1.3 Global Botulism Illness Drugs Market by Application
1.3.1 Global Botulism Illness Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Botulism Illness Drugs Market by Regions
1.4.1 Global Botulism Illness Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Botulism Illness Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Botulism Illness Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Botulism Illness Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Botulism Illness Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Botulism Illness Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Botulism Illness Drugs (2014-2024)
2 Manufacturers Profiles
2.1 Eisai
2.1.1 Business Overview
2.1.2 Botulism Illness Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eisai Botulism Illness Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Microbiotix
2.2.1 Business Overview
2.2.2 Botulism Illness Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Microbiotix Botulism Illness Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Botulism Illness Drugs Market Competition, by Players
3.1 Global Botulism Illness Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Botulism Illness Drugs Players Market Share
3.2.2 Top 10 Botulism Illness Drugs Players Market Share
3.3 Market Competition Trend
4 Global Botulism Illness Drugs Market Size by Regions
4.1 Global Botulism Illness Drugs Revenue and Market Share by Regions
4.2 North America Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
5 North America Botulism Illness Drugs Revenue by Countries
5.1 North America Botulism Illness Drugs Revenue by Countries (2014-2019)
5.2 USA Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
6 Europe Botulism Illness Drugs Revenue by Countries
6.1 Europe Botulism Illness Drugs Revenue by Countries (2014-2019)
6.2 Germany Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
6.4 France Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Botulism Illness Drugs Revenue by Countries
7.1 Asia-Pacific Botulism Illness Drugs Revenue by Countries (2014-2019)
7.2 China Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
7.5 India Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
8 South America Botulism Illness Drugs Revenue by Countries
8.1 South America Botulism Illness Drugs Revenue by Countries (2014-2019)
8.2 Brazil Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Botulism Illness Drugs by Countries
9.1 Middle East and Africa Botulism Illness Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
10 Global Botulism Illness Drugs Market Segment by Type
10.1 Global Botulism Illness Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Botulism Illness Drugs Market Forecast by Type (2019-2024)
10.3 Antibiotics Revenue Growth Rate (2014-2024)
10.4 Antitoxins Revenue Growth Rate (2014-2024)
10.5 Other Revenue Growth Rate (2014-2024)
11 Global Botulism Illness Drugs Market Segment by Application
11.1 Global Botulism Illness Drugs Revenue Market Share by Application (2014-2019)
11.2 Botulism Illness Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Botulism Illness Drugs Market Size Forecast (2019-2024)
12.1 Global Botulism Illness Drugs Market Size Forecast (2019-2024)
12.2 Global Botulism Illness Drugs Market Forecast by Regions (2019-2024)
12.3 North America Botulism Illness Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Botulism Illness Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Botulism Illness Drugs Revenue Market Forecast (2019-2024)
12.6 South America Botulism Illness Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Botulism Illness Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Botulism Illness Drugs Picture
Table Product Specifications of Botulism Illness Drugs
Table Global Botulism Illness Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Botulism Illness Drugs Revenue Market Share by Types in 2018
Figure Antibiotics Picture
Figure Antitoxins Picture
Figure Other Picture
Table Global Botulism Illness Drugs Revenue (Million USD) by Application (2014-2024)
Figure Botulism Illness Drugs Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Botulism Illness Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Botulism Illness Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Botulism Illness Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Botulism Illness Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Botulism Illness Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Botulism Illness Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Botulism Illness Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Botulism Illness Drugs Type and Applications
Table Eisai Botulism Illness Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Microbiotix Basic Information, Manufacturing Base and Competitors
Table Microbiotix Botulism Illness Drugs Type and Applications
Table Microbiotix Botulism Illness Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Botulism Illness Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Botulism Illness Drugs Revenue Share by Players (2014-2019)
Figure Global Botulism Illness Drugs Revenue Share by Players in 2017
Figure Global Botulism Illness Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Botulism Illness Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Botulism Illness Drugs Revenue Market Share in 2018
Figure Global Botulism Illness Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Botulism Illness Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Botulism Illness Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Botulism Illness Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Botulism Illness Drugs Revenue Market Share by Regions in 2018
Figure North America Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure South America Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Table North America Botulism Illness Drugs Revenue by Countries (2014-2019)
Table North America Botulism Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Botulism Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Botulism Illness Drugs Revenue Market Share by Countries in 2018
Figure USA Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Table Europe Botulism Illness Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Botulism Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Botulism Illness Drugs Revenue Market Share by Countries in 2018
Figure Germany Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure UK Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure France Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Botulism Illness Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Botulism Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Botulism Illness Drugs Revenue Market Share by Countries in 2018
Figure China Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure India Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Table South America Botulism Illness Drugs Revenue by Countries (2014-2019)
Table South America Botulism Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Botulism Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Botulism Illness Drugs Revenue Market Share by Countries in 2018
Figure Brazil Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Botulism Illness Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Botulism Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Botulism Illness Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Botulism Illness Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Botulism Illness Drugs Revenue and Growth Rate (2014-2019)
Table Global Botulism Illness Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Botulism Illness Drugs Revenue Share by Type (2014-2019)
Figure Global Botulism Illness Drugs Revenue Share by Type (2014-2019)
Figure Global Botulism Illness Drugs Revenue Share by Type in 2019
Table Global Botulism Illness Drugs Revenue Forecast by Type (2019-2024)
Figure Global Botulism Illness Drugs Market Share Forecast by Type (2019-2024)
Figure Global Antibiotics Revenue Growth Rate (2014-2019)
Figure Global Antitoxins Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Botulism Illness Drugs Revenue by Application (2014-2019)
Table Global Botulism Illness Drugs Revenue Share by Application (2014-2019)
Figure Global Botulism Illness Drugs Revenue Share by Application (2014-2019)
Figure Global Botulism Illness Drugs Revenue Share by Application in 2019
Table Global Botulism Illness Drugs Revenue Forecast by Application (2019-2024)
Figure Global Botulism Illness Drugs Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Botulism Illness Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Botulism Illness Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Botulism Illness Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Botulism Illness Drugs Revenue Market Forecast (2019-2024)
Figure Europe Botulism Illness Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Botulism Illness Drugs Revenue Market Forecast (2019-2024)
Figure South America Botulism Illness Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Botulism Illness Drugs Revenue Market Forecast (2019-2024)